BBI SOLUTIONS OEM LIMITED – Trademark Portfolio
Entity Type: 11
BBI SOLUTIONS OEM LIMITED holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 7 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in CARDIFF, SOUTH GLAMORGAN.
THE COURTYARD, 73 TY GLAS AVENUE
CARDIFF, SOUTH GLAMORGAN CF14 5DX , GB
Showing of trademarks Trademarks
Trademark Classifications
BBI SOLUTIONS OEM LIMITED's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BBI SOLUTIONS OEM LIMITED have?
BBI SOLUTIONS OEM LIMITED has 9 U.S. trademarks filed with the USPTO. Of these, 2 pending, 3 abandoned, 3 cancelled.
What trademark classes does BBI SOLUTIONS OEM LIMITED file in?
BBI SOLUTIONS OEM LIMITED files trademarks across 7 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What is BBI SOLUTIONS OEM LIMITED's trademark registration success rate?
BBI SOLUTIONS OEM LIMITED has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.